跳至主要内容
临床试验/CTRI/2018/06/014573
CTRI/2018/06/014573已完成不适用

A comparative evaluation of safety and efficacy of formoterol with tiotropium bromide and formoterol with glycopyrronium in patients of COPD

Department of pharmacology1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2018年2月7日最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
160
试验地点
1
主要终点
Pulmonary function test

研究概览

简要总结

Chronic obstructive pulmonary disease (COPD) is a leading cause of death especially in developing countries like India. To improve the health condition among the COPD patients a better yet cost effective treatment combination is required. This study is focussed on finding out an effective treatment combination for such patients.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • patients with grade II and III COPD in age group of
  • 65 of both genders will be enrolled in the study.

排除标准

  • Complicated cases of COPD patients Patients with clinically significant lung disease other than COPD Patients with respiratory failure Patients who are on systemic corticosteroid therapy Pregnant and Lactating patients.
  • Psychotic patients.
  • Critically ill patients.
  • Patients with comorbid conditions like myocardial infarction, diabetes mellitus 5 Known cases of HIV/HBsAg /Anti-HCV and immuno-compromised patients.

结局指标

主要结局

Pulmonary function test

时间窗: 3 month

次要结局

  • safety and cost effectiveness(3 month)

研究者

申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验

comparison of various respiratory medicines in... | 临床试验